Volume 30, Issue 2

Search all Breast Cancer articles

March 2023

16 articles in this issue

Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018
Keiichiro Tada
Hiraku Kumamaru
Hiromitsu Jinno
Special Article Open access 22 December 2022 Pages: 157 - 166
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches
Hong-My Nguyen
Wyatt Paulishak
Laurence Wood
Review Article 18 November 2022 Pages: 167 - 186
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
Karolina Anuszkiewicz
Jerzy Jankau
Martyna Kur
Review Article Open access 26 December 2022 Pages: 187 - 199
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients
Mohammed Tarek Hasan
Mohamed Hamouda
Mohamed Ibrahim Gbreel
Review Article Open access 09 January 2023 Pages: 200 - 214
Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors
Stacyann Bailey
Charlotte Ezratty
Jenny J. Lin
Original Article 01 November 2022 Pages: 215 - 225
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up
Sriyani Padmalatha Konara Mudiyanselage
Yi-Lin Wu
Nai-Ying Ko
Original Article 01 November 2022 Pages: 226 - 240
Performance analysis of screening mammography in Asian women under 40 years
Mi-ri Kwon
Yoosoo Chang
Shin Ho Kook
Original Article 05 November 2022 Pages: 241 - 248
A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer
Jessica T. Watzek
Louisa G. Gordon
Sandra C. Hayes
Original Article 03 December 2022 Pages: 249 - 258
High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach
Jinah Chu
Kyueng-Whan Min
Sung-Im Do
Original Article 07 December 2022 Pages: 259 - 270
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors
Masahiro Manfuku
Tomohiko Nishigami
Kazuhiro Sumiyoshi
Original Article 18 December 2022 Pages: 271 - 281
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study
Terufumi Kawamoto
Naoto Shikama
Naoki Nakamura
Original Article 17 December 2022 Pages: 282 - 292
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)
Manabu Futamura
Kazuhiro Ishihara
Nobuhisa Matsuhasih
Original Article Open access 07 January 2023 Pages: 293 - 301
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan
Rena Yamakado
Makoto Ishitobi
Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Original Article 17 December 2022 Pages: 302 - 308
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study
Tomoe Taji
Nina Odan
Hirofumi Suwa
Original Article 22 December 2022 Pages: 309 - 314
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients
Caroline Bailleux
Antoine Arnaud
Pierre-Etienne Heudel
Original Article Open access 05 January 2023 Pages: 315 - 328
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort
Laetitia Collet
Lauriane Eberst
Thomas Bachelot
Original Article 11 January 2023 Pages: 329 - 341

Volume 30, Issue 2

Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018

Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches

What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options

Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients

Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors

Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up

Performance analysis of screening mammography in Asian women under 40 years

A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer

High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach

Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors

Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study

Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)

Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan

Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study

CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort

Navigation